Results 191 to 200 of about 295,251 (340)

Deep Learning‐Coupled Metabolic Heat Integrated Sensing System for Noninvasive Continuous Monitoring of Blood Glucose

Advanced Intelligent Systems, EarlyView.
A portable, wearable device based on metabolic heat integrated sensing and deep learning enables continuous blood glucose (BG) monitoring. The system uses a gate recurrent unit model for real‐time BG prediction, achieving accuracy comparable to commercial noninvasive meters.
Haolin Wang, Chuanjie Yao, Zhibo Liu, Xinze Wang, Zhengjie Liu, Tao Zhang, Xinshuo Huang, LinGe Wang, Yuedan Wang, Gemin Xiao, Shady Farah, Hui‐jiuan Chen, Xi Xie   +12 more
wiley   +1 more source

Crohn's disease but not ulcerative colitis elevated risk of end-stage renal disease and mortality: A Taiwan retrospective cohort study. [PDF]

Medicine (Baltimore)
Chuang MC, Hsu TJ, Tsai FJ, Hsu JL, Tsai TY.   +4 more
europepmc   +1 more source

Infrainguinal bypass in patients with end-stage renal disease

, 1993

openalex   +1 more source

Horner Syndrome Following Permcath Insertion in a Child with End-Stage Renal Disease: A Case Report. [PDF]

Iran J Child Neurol
Mohkam M, Fatollahierad S, Ahmadabadi F, Khalili M.   +3 more
europepmc   +1 more source

Fluoride enigma in end stage renal disease. [PDF]

Bioinformation
Sharon Rose P, Shashidhar KN, Munilakshmi U, Meghanath M.   +3 more
europepmc   +1 more source

Hyperhomocysteinemia and traditional cardiovascular disease risk factors in end-stage renal disease patients on dialysis: a case-control study

, 1995
Andrew G. Bostom, Douglas Shemin, Kate L. Lapane, Joshua W. Miller, Patrice Sutherland, Marie Nadeau, Elias Seyoum, Wilburta J. Hartman, Ronald L. Prior, Peter W.F. Wilson, Jacob Selhub   +10 more
openalex   +1 more source

TP53‐Mutated Myeloid Neoplasms: 2024 Update on Diagnosis, Risk‐Stratification, and Management

American Journal of Hematology, EarlyView.
ABSTRACT Alterations in the tumor suppressor gene TP53 are common in human cancers and are associated with an aggressive nature. Approximately 8%–12% of myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML) harbor TP53 mutations (TP53mut) and present immense challenges due to inherent chemoresistance and poor outcomes.
Mithun Vinod Shah, Daniel A. Arber, Devendra K. Hiwase   +2 more
wiley   +1 more source

Metabolic syndrome in end stage renal disease

Journal of Research in Medical Sciences, 2014
Mojgan Mortazavi, Shiva Seyrafian, Nafiseh Moein, Diana Taheri, Shahaboddin Dolatkhah   +4 more
doaj  

Comparative Analysis of Primary Sarcopenia and End-Stage Renal Disease-Related Muscle Wasting Using Multi-Omics Approaches. [PDF]

J Cachexia Sarcopenia Muscle
Setoyama D, Han D, Tian J, Lee HY, Shin HS, Nga HT, Nguyen TL, Moon JS, Jang HJ, Kim E, Choe SK, Ju SH, Choi DE, Kwon O, Yi HS.   +14 more
europepmc   +1 more source

Cardiac troponin T in end-stage renal disease patients undergoing chronic maintenance hemodialysis [PDF]

, 1995
H. A. Katus, Christlieb Haller, Margit Müller-Bardorff, Thomas Scheffold, Andrew Remppis   +4 more
openalex   +1 more source